Sara Madrid joined White & Case in 2008 and she has been involved in financial regulatory matters, infrastructure projects, public procurement, mergers and acquisitions, antitrust matters, arbitration and litigation, as well as general corporate matters.
Her practice has focused in regulatory matters for financial institutions with substantial operations in Mexico before the Ministry of Finance and Public Credit (SHCP), National Banking and Securities Commission (CNBV), National Commission of the Retirement Savings System (CONSAR), National Commission for the Protection and Defense of the Users of Financial Services (CONDUSEF), National Insurance and Bonding Commission (CNSF), Federal Attorney's Office of Consumer (PROFECO), the Central Bank of Mexico (BANXICO) and the Mexican Stock Exchange (BMV).
Also, she has been involved in regulatory matters for health institutions with the Federal Commission for the Protection against Sanitary Risk (COFEPRIS), the National Transplant Center (CENATRA) and the National Blood Transfusion Center (CNTS).
Sara Madrid has been substantially supporting White & Case Global Pro Bono Practice and has been appointed as Pro Bono Liaison of Mexico City Office.
Experience
Advising leading global financial groups in the development and description of a system to prevent conflicts of interest between the financial entities comprising the respective financial groups (2016).
Advising a leading global financial group in the first stage of its corporate restructuring with authorization process before the SHCP, CNBV, CNSF, CONSAR, among others (2016).
Advising leading global financial institutions in the development of the legal implementation of the recovery actions provided for within its Contingency Plan (2016).
Advising a leading global bank with a regulatory compliance matrix, allowing the bank to identify all applicable obligations to its operations, including the identification of risks and applicable fines for compliance failures (2016).
Advising a leading global blank with the regulatory process before the CNBV relating to an investment to be authorized under the Mexican Banking Law (2016).
Advising a Mexican broker dealer in the regulatory process to act as non-lead underwriter for corporate and structured bonds in Mexico (2016).
Advising a Mexican Hospital and a US company leading in providing services of regenerative medicine, in regulatory matters with Cofepris to import stem cells into Mexico for therapeutically purposes only (2015).
Advising different financial institutions about the implementation of new regulatory obligations set forth in the 2014 Financial Reform Bill. The advice included, among other subjects, the preparation of amendments required by the bylaws and stock certificates of financial holding companies, banks and brokerage firms (2014).
Represented Hipotecaria Crédito y Casa, the third-largest mortgage originator in Mexico, in its orderly liquidation process, including the restructuring and payment in kind of its domestic market publicly traded notes (2013).
Represented a US based supplier of automotive components to automotive original equipment manufacturers, in a shareholders dispute with its Mexican partner in an arbitration proceeding before the International Centre for Dispute Resolution (ICDR) (2012).
